CDC Lab Chief in Anthrax Debacle Resigns

Wednesday, 23 Jul 2014 01:45 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
The director of a government bioterror lab behind the potential exposure of workers to live anthrax has resigned, the U.S. Centers for Disease Control and Prevention said on Wednesday.
 
Michael Farrell, head of the CDC's Bioterror Rapid Response and Advanced Technology Laboratory (BRRAT) in Atlanta, had been reassigned from his position last month after the agency disclosed the safety breaches. He submitted his resignation on Tuesday, the CDC said.

“I can confirm that he was the team lead for the BRRAT lab since 2009 and that he’s resigned from that position,” said CDC spokesman Thomas Skinner.

Farrell was the first CDC employee to leave his post over the incident, in which more than 80 government lab workers were potentially exposed to the dangerous bacteria after samples that had not been properly inactivated left the BRRAT lab in June. No one has fallen ill as a result of the incident, and the CDC later concluded that the true risk of exposure was minimal, if at all.

But the lapse at the CDC prompted new scrutiny into how the agency protects the public from potentially dangerous research and a pledge from its director, Dr. Thomas Frieden, to change the culture of safety among its staff.

Frieden has said the agency would consider disciplinary action against any staff members found to have knowingly violated safety protocols or to have failed to report breaches.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Ebola Treatment Strategy: Keep Patients Alive as Body Fights Back

Monday, 20 Oct 2014 17:08 PM

People who shared an apartment with the country's first Ebola patient are emerging from quarantine healthy. And while Th . . .

Goodbye to Reading Glasses?

Monday, 20 Oct 2014 16:23 PM

A new implantable eye device might make reading glasses a thing of the past, researchers report.
Many people over a . . .

Herceptin Boosts Breast Cancer Survival: Mayo Clinic

Monday, 20 Oct 2014 16:18 PM

Adding the drug Herceptin to chemotherapy for certain breast cancer patients increases overall survival and reduces the  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved